Takeda Pharmaceutical International AG Singapore

Takeda Pharmaceutical Company Limited is a global, values-based, R&D-driven biopharmaceutical leader headquartered in Japan, committed to bringing Better Health and a Brighter Future to patients by translating science into highly innovative medicines. In Singapore, Takeda has been a key healthcare partner contributing in the therapeutic areas of oncology, plasma-derived therapies and rare diseases.

See below for the Latest Takeda Pharmaceutical International AG Singapore News, Analysis, Profit Results, Share Price Information, and Commentary.

Why rare disease policies are critical to ensure equitable access to treatment for rare disease communities in Southeast Asia

Patient empowerment and policy change were emphasised as key points to address during the 2nd Southeast Asia Rare Disease Summit.

Sponsored Articles

Why rare disease policies are critical to ensure equitable access to treatment for rare disease communities in Southeast Asia

Patient empowerment and policy change were emphasised as key points to address during the 2nd Southeast Asia Rare Disease Summit.

Sponsored Articles

Takeda Pharmaceuticals secures Healthcare Asia Pharma Awards for Patient Assistance Programme

The affordability-based programme is designed to be equitable and sustainable.

Event News